Table 2.

Impact of clofarabine on patients with a high MRD (N=8)

MRD evolution	Number (%)
Improvement of one logarithm	1 (12.5%)
Improvement of less than one logarithm	3 (37.5%)
Stable	3 (37.5%)
Non evaluable	1 (12.5%)